Cost benefit and cost effectiveness analysis of methotrexate and Goeckerman theraoy for psoriasis: A study revisited
Publication
, Journal Article
Chen, SC; Garber, AM
Published in: Medical Decision Making
1998
Duke Scholars
Published In
Medical Decision Making
ISSN
0272-989X
Publication Date
1998
Volume
18
Issue
4
Start / End Page
447 / 447
Publisher
SAGE Publications
Related Subject Headings
- Health Policy & Services
- 4206 Public health
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services
Citation
APA
Chicago
ICMJE
MLA
NLM
Chen, S. C., & Garber, A. M. (1998). Cost benefit and cost effectiveness analysis of methotrexate and Goeckerman theraoy for psoriasis: A study revisited. Medical Decision Making, 18(4), 447–447.
Chen, S. C., and A. M. Garber. “Cost benefit and cost effectiveness analysis of methotrexate and Goeckerman theraoy for psoriasis: A study revisited.” Medical Decision Making 18, no. 4 (1998): 447–447.
Chen SC, Garber AM. Cost benefit and cost effectiveness analysis of methotrexate and Goeckerman theraoy for psoriasis: A study revisited. Medical Decision Making. 1998;18(4):447–447.
Chen, S. C., and A. M. Garber. “Cost benefit and cost effectiveness analysis of methotrexate and Goeckerman theraoy for psoriasis: A study revisited.” Medical Decision Making, vol. 18, no. 4, SAGE Publications, 1998, pp. 447–447.
Chen SC, Garber AM. Cost benefit and cost effectiveness analysis of methotrexate and Goeckerman theraoy for psoriasis: A study revisited. Medical Decision Making. SAGE Publications; 1998;18(4):447–447.
Published In
Medical Decision Making
ISSN
0272-989X
Publication Date
1998
Volume
18
Issue
4
Start / End Page
447 / 447
Publisher
SAGE Publications
Related Subject Headings
- Health Policy & Services
- 4206 Public health
- 4203 Health services and systems
- 3801 Applied economics
- 1402 Applied Economics
- 1117 Public Health and Health Services